HEADER TRANSFERASE 10-SEP-14 3WYY TITLE CRYSTAL STRUCTURE OF HUMAN MPS1 CATALYTIC DOMAIN IN COMPLEX WITH (E)- TITLE 2 3-(4-((6-(((3S,5S,7S)-ADAMANTAN-1-YL)AMINO)-4-AMINO-5-CYANOPYRIDIN-2- TITLE 3 YL)AMINO)-2-(CYANOMETHOXY)PHENYL)-N-(2-METHOXYETHYL)ACRYLAMIDE COMPND MOL_ID: 1; COMPND 2 MOLECULE: DUAL SPECIFICITY PROTEIN KINASE TTK; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: MPS1 (TTK) KINASE, UNP RESIDUES 516-820; COMPND 5 SYNONYM: PHOSPHOTYROSINE PICKED THREONINE-PROTEIN KINASE, PYT; COMPND 6 EC: 2.7.12.1; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: TTK, MPS1, MPS1L1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS KINASE, SERINE/THREONINE-PROTEIN KINASE, TRANSFERASE, INHIBITOR KEYWDS 2 COMPLEX, ATP BINDING EXPDTA X-RAY DIFFRACTION AUTHOR K.KUSAKABE,N.IDE,Y.DAIGO,T.ITOH,T.YAMAMOTO,E.KOJIMA,Y.MITSUOKA, AUTHOR 2 G.TADANO,S.TAGASHIRA,K.HIGASHINO,Y.OKANO,Y.SATO,M.INOUE,M.IGUCHI, AUTHOR 3 T.KANAZAWA,Y.ISHIOKA,K.DOHI,Y.KIDO,S.SAKAMOTO,S.ANDO,M.MAEDA, AUTHOR 4 M.HIGAKI,H.YOSHIZAWA,H.MURAI,Y.NAKAMURA REVDAT 3 24-AUG-22 3WYY 1 JRNL REMARK SEQADV REVDAT 2 22-NOV-17 3WYY 1 REMARK REVDAT 1 08-APR-15 3WYY 0 JRNL AUTH K.KUSAKABE,N.IDE,Y.DAIGO,T.ITOH,T.YAMAMOTO,E.KOJIMA, JRNL AUTH 2 Y.MITSUOKA,G.TADANO,S.TAGASHIRA,K.HIGASHINO,Y.OKANO,Y.SATO, JRNL AUTH 3 M.INOUE,M.IGUCHI,T.KANAZAWA,Y.ISHIOKA,K.DOHI,Y.KIDO, JRNL AUTH 4 S.SAKAMOTO,S.ANDO,M.MAEDA,M.HIGAKI,H.YOSHIZAWA,H.MURAI, JRNL AUTH 5 Y.NAKAMURA JRNL TITL A UNIQUE HINGE BINDER OF EXTREMELY SELECTIVE JRNL TITL 2 AMINOPYRIDINE-BASED MPS1 (TTK) KINASE INHIBITORS WITH JRNL TITL 3 CELLULAR ACTIVITY. JRNL REF BIOORG.MED.CHEM. V. 23 2247 2015 JRNL REFN ESSN 1464-3391 JRNL PMID 25801152 JRNL DOI 10.1016/J.BMC.2015.02.042 REMARK 2 REMARK 2 RESOLUTION. 3.05 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.7.0029 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.05 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 89.6 REMARK 3 NUMBER OF REFLECTIONS : 6871 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.229 REMARK 3 R VALUE (WORKING SET) : 0.223 REMARK 3 FREE R VALUE : 0.281 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 9.900 REMARK 3 FREE R VALUE TEST SET COUNT : 756 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 3.05 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 3.13 REMARK 3 REFLECTION IN BIN (WORKING SET) : 468 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 90.99 REMARK 3 BIN R VALUE (WORKING SET) : 0.3100 REMARK 3 BIN FREE R VALUE SET COUNT : 67 REMARK 3 BIN FREE R VALUE : 0.3680 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1971 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 40 REMARK 3 SOLVENT ATOMS : 0 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 67.15 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -4.17000 REMARK 3 B22 (A**2) : 5.24000 REMARK 3 B33 (A**2) : -1.07000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): 0.497 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.389 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 21.827 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.929 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.878 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2056 ; 0.005 ; 0.019 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 2796 ; 0.985 ; 1.985 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 254 ; 4.586 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 84 ;42.330 ;25.238 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 323 ;15.059 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 5 ;18.835 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 314 ; 0.059 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 1542 ; 0.004 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN USED IF PRESENT IN REMARK 3 THE INPUT U VALUES : REFINED INDIVIDUALLY REMARK 4 REMARK 4 3WYY COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 11-SEP-14. REMARK 100 THE DEPOSITION ID IS D_1000096968. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 19-SEP-08 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU MICROMAX-007 HF REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IV++ REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO, HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK, HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 7627 REMARK 200 RESOLUTION RANGE HIGH (A) : 3.050 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 90.0 REMARK 200 DATA REDUNDANCY : 3.400 REMARK 200 R MERGE (I) : 0.10200 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 8.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 3.05 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.10 REMARK 200 COMPLETENESS FOR SHELL (%) : 93.9 REMARK 200 DATA REDUNDANCY IN SHELL : 3.10 REMARK 200 R MERGE FOR SHELL (I) : 0.56800 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 57.76 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.91 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.35M SODIUM MALONATE, 7%(W/V) REMARK 280 PEG3350, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: I 2 2 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X,Y,-Z REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z+1/2 REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 35.29350 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 53.20150 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 57.15900 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 35.29350 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 53.20150 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 57.15900 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 35.29350 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 53.20150 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 57.15900 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 35.29350 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 53.20150 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 57.15900 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1640 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 22850 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -14.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 -70.58700 REMARK 350 BIOMT2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 515 REMARK 465 ASP A 674 REMARK 465 THR A 675 REMARK 465 THR A 676 REMARK 465 SER A 677 REMARK 465 VAL A 678 REMARK 465 VAL A 679 REMARK 465 LYS A 680 REMARK 465 ASP A 681 REMARK 465 SER A 682 REMARK 465 GLN A 683 REMARK 465 VAL A 684 REMARK 465 SER A 700 REMARK 465 SER A 701 REMARK 465 ARG A 702 REMARK 465 GLU A 703 REMARK 465 ASN A 704 REMARK 465 GLY A 705 REMARK 465 LYS A 706 REMARK 465 SER A 707 REMARK 465 LYS A 708 REMARK 465 SER A 709 REMARK 465 LYS A 710 REMARK 465 HIS A 796 REMARK 465 PRO A 797 REMARK 465 VAL A 798 REMARK 465 ASN A 799 REMARK 465 GLN A 800 REMARK 465 MET A 801 REMARK 465 ALA A 802 REMARK 465 LYS A 803 REMARK 465 GLY A 804 REMARK 465 THR A 805 REMARK 465 THR A 806 REMARK 465 GLU A 807 REMARK 465 GLU A 808 REMARK 465 MET A 809 REMARK 465 LYS A 810 REMARK 465 TYR A 811 REMARK 465 VAL A 812 REMARK 465 LEU A 813 REMARK 465 GLY A 814 REMARK 465 GLN A 815 REMARK 465 LEU A 816 REMARK 465 VAL A 817 REMARK 465 GLY A 818 REMARK 465 LEU A 819 REMARK 465 ASN A 820 REMARK 465 LEU A 821 REMARK 465 VAL A 822 REMARK 465 PRO A 823 REMARK 465 ARG A 824 REMARK 465 GLY A 825 REMARK 465 SER A 826 REMARK 465 ALA A 827 REMARK 465 ALA A 828 REMARK 465 GLY A 829 REMARK 465 HIS A 830 REMARK 465 HIS A 831 REMARK 465 HIS A 832 REMARK 465 HIS A 833 REMARK 465 HIS A 834 REMARK 465 HIS A 835 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 516 CG CD OE1 OE2 REMARK 470 VAL A 520 CG1 CG2 REMARK 470 ARG A 523 CG CD NE CZ NH1 NH2 REMARK 470 ILE A 524 CG1 CG2 CD1 REMARK 470 SER A 526 OG REMARK 470 LYS A 529 CE NZ REMARK 470 SER A 536 OG REMARK 470 LYS A 538 CE NZ REMARK 470 LYS A 546 CD CE NZ REMARK 470 LYS A 547 CG CD CE NZ REMARK 470 GLU A 558 CD OE1 OE2 REMARK 470 GLU A 559 CG CD OE1 OE2 REMARK 470 ASP A 561 CG OD1 OD2 REMARK 470 ASN A 562 CB CG OD1 ND2 REMARK 470 GLN A 563 CG CD OE1 NE2 REMARK 470 GLN A 580 CG CD OE1 NE2 REMARK 470 LYS A 614 CE NZ REMARK 470 LYS A 615 CG CD CE NZ REMARK 470 LYS A 616 CG CD CE NZ REMARK 470 LYS A 617 CG CD CE NZ REMARK 470 SER A 618 OG REMARK 470 TRP A 622 CG CD1 CD2 NE1 CE2 CE3 CZ2 REMARK 470 TRP A 622 CZ3 CH2 REMARK 470 GLU A 623 CG CD OE1 OE2 REMARK 470 LYS A 625 CG CD CE NZ REMARK 470 LYS A 649 NZ REMARK 470 ASP A 657 CG OD1 OD2 REMARK 470 GLN A 672 CG CD OE1 NE2 REMARK 470 ILE A 695 CG1 CG2 CD1 REMARK 470 LYS A 696 CE NZ REMARK 470 ASP A 697 CG OD1 OD2 REMARK 470 SER A 699 OG REMARK 470 ILE A 711 CG1 CG2 CD1 REMARK 470 GLN A 736 CG CD OE1 NE2 REMARK 470 ILE A 738 CG1 CG2 CD1 REMARK 470 ILE A 741 CG1 CG2 CD1 REMARK 470 HIS A 745 CG ND1 CD2 CE1 NE2 REMARK 470 PHE A 756 CD2 REMARK 470 LYS A 762 CG CD CE NZ REMARK 470 LEU A 768 N REMARK 470 LYS A 769 CD CE NZ REMARK 470 LYS A 773 CE NZ REMARK 470 LYS A 777 CG CD CE NZ REMARK 470 THR A 795 OG1 CG2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LEU A 528 -73.82 -90.61 REMARK 500 SER A 536 12.83 -148.20 REMARK 500 ALA A 560 143.61 -174.10 REMARK 500 THR A 594 -145.87 -118.50 REMARK 500 SER A 646 23.64 -72.82 REMARK 500 ASP A 647 53.41 -158.98 REMARK 500 ASP A 697 40.96 -72.15 REMARK 500 THR A 728 -66.42 -106.77 REMARK 500 PRO A 733 -4.46 -58.79 REMARK 500 PHE A 734 22.34 -141.35 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE O17 A 901 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3WYX RELATED DB: PDB REMARK 900 THE SAME PROTEIN COMPLEXED WITH 6-((3-(CYANOMETHOXY)-4-(1-METHYL-1H- REMARK 900 PYRAZOL-4-YL)PHENYL)AMINO)-2-(CYCLOHEXYLAMINO)NICOTINONITRILE DBREF 3WYY A 516 820 UNP P33981 TTK_HUMAN 516 820 SEQADV 3WYY MET A 515 UNP P33981 EXPRESSION TAG SEQADV 3WYY LEU A 821 UNP P33981 EXPRESSION TAG SEQADV 3WYY VAL A 822 UNP P33981 EXPRESSION TAG SEQADV 3WYY PRO A 823 UNP P33981 EXPRESSION TAG SEQADV 3WYY ARG A 824 UNP P33981 EXPRESSION TAG SEQADV 3WYY GLY A 825 UNP P33981 EXPRESSION TAG SEQADV 3WYY SER A 826 UNP P33981 EXPRESSION TAG SEQADV 3WYY ALA A 827 UNP P33981 EXPRESSION TAG SEQADV 3WYY ALA A 828 UNP P33981 EXPRESSION TAG SEQADV 3WYY GLY A 829 UNP P33981 EXPRESSION TAG SEQADV 3WYY HIS A 830 UNP P33981 EXPRESSION TAG SEQADV 3WYY HIS A 831 UNP P33981 EXPRESSION TAG SEQADV 3WYY HIS A 832 UNP P33981 EXPRESSION TAG SEQADV 3WYY HIS A 833 UNP P33981 EXPRESSION TAG SEQADV 3WYY HIS A 834 UNP P33981 EXPRESSION TAG SEQADV 3WYY HIS A 835 UNP P33981 EXPRESSION TAG SEQRES 1 A 321 MET GLU CYS ILE SER VAL LYS GLY ARG ILE TYR SER ILE SEQRES 2 A 321 LEU LYS GLN ILE GLY SER GLY GLY SER SER LYS VAL PHE SEQRES 3 A 321 GLN VAL LEU ASN GLU LYS LYS GLN ILE TYR ALA ILE LYS SEQRES 4 A 321 TYR VAL ASN LEU GLU GLU ALA ASP ASN GLN THR LEU ASP SEQRES 5 A 321 SER TYR ARG ASN GLU ILE ALA TYR LEU ASN LYS LEU GLN SEQRES 6 A 321 GLN HIS SER ASP LYS ILE ILE ARG LEU TYR ASP TYR GLU SEQRES 7 A 321 ILE THR ASP GLN TYR ILE TYR MET VAL MET GLU CYS GLY SEQRES 8 A 321 ASN ILE ASP LEU ASN SER TRP LEU LYS LYS LYS LYS SER SEQRES 9 A 321 ILE ASP PRO TRP GLU ARG LYS SER TYR TRP LYS ASN MET SEQRES 10 A 321 LEU GLU ALA VAL HIS THR ILE HIS GLN HIS GLY ILE VAL SEQRES 11 A 321 HIS SER ASP LEU LYS PRO ALA ASN PHE LEU ILE VAL ASP SEQRES 12 A 321 GLY MET LEU LYS LEU ILE ASP PHE GLY ILE ALA ASN GLN SEQRES 13 A 321 MET GLN PRO ASP THR THR SER VAL VAL LYS ASP SER GLN SEQRES 14 A 321 VAL GLY THR VAL ASN TYR MET PRO PRO GLU ALA ILE LYS SEQRES 15 A 321 ASP MET SER SER SER ARG GLU ASN GLY LYS SER LYS SER SEQRES 16 A 321 LYS ILE SER PRO LYS SER ASP VAL TRP SER LEU GLY CYS SEQRES 17 A 321 ILE LEU TYR TYR MET THR TYR GLY LYS THR PRO PHE GLN SEQRES 18 A 321 GLN ILE ILE ASN GLN ILE SER LYS LEU HIS ALA ILE ILE SEQRES 19 A 321 ASP PRO ASN HIS GLU ILE GLU PHE PRO ASP ILE PRO GLU SEQRES 20 A 321 LYS ASP LEU GLN ASP VAL LEU LYS CYS CYS LEU LYS ARG SEQRES 21 A 321 ASP PRO LYS GLN ARG ILE SER ILE PRO GLU LEU LEU ALA SEQRES 22 A 321 HIS PRO TYR VAL GLN ILE GLN THR HIS PRO VAL ASN GLN SEQRES 23 A 321 MET ALA LYS GLY THR THR GLU GLU MET LYS TYR VAL LEU SEQRES 24 A 321 GLY GLN LEU VAL GLY LEU ASN LEU VAL PRO ARG GLY SER SEQRES 25 A 321 ALA ALA GLY HIS HIS HIS HIS HIS HIS HET O17 A 901 40 HETNAM O17 (2E)-3-[4-({4-AMINO-5-CYANO-6-[(3S,5S,7S)- HETNAM 2 O17 TRICYCLO[3.3.1.1~3,7~]DEC-1-YLAMINO]PYRIDIN-2- HETNAM 3 O17 YL}AMINO)-2-(CYANOMETHOXY)PHENYL]-N-(2-METHOXYETHYL) HETNAM 4 O17 PROP-2-ENAMIDE FORMUL 2 O17 C30 H35 N7 O3 HELIX 1 1 ASP A 561 LEU A 578 1 18 HELIX 2 2 LEU A 609 LYS A 614 1 6 HELIX 3 3 ASP A 620 HIS A 641 1 22 HELIX 4 4 LYS A 649 ALA A 651 5 3 HELIX 5 5 PRO A 691 ASP A 697 1 7 HELIX 6 6 PRO A 713 GLY A 730 1 18 HELIX 7 7 ASN A 739 ASP A 749 1 11 HELIX 8 8 GLU A 761 VAL A 767 1 7 HELIX 9 9 LYS A 769 LEU A 772 1 4 HELIX 10 10 SER A 781 LEU A 786 1 6 HELIX 11 11 HIS A 788 ILE A 793 1 6 SHEET 1 A 6 CYS A 517 SER A 519 0 SHEET 2 A 6 ILE A 524 SER A 533 -1 O TYR A 525 N ILE A 518 SHEET 3 A 6 SER A 537 LEU A 543 -1 O VAL A 539 N ILE A 531 SHEET 4 A 6 ILE A 549 ASN A 556 -1 O TYR A 554 N LYS A 538 SHEET 5 A 6 TYR A 597 MET A 602 -1 O MET A 602 N ALA A 551 SHEET 6 A 6 LEU A 588 ILE A 593 -1 N ASP A 590 O VAL A 601 SHEET 1 B 3 ILE A 607 ASP A 608 0 SHEET 2 B 3 PHE A 653 ILE A 655 -1 O ILE A 655 N ILE A 607 SHEET 3 B 3 LEU A 660 LEU A 662 -1 O LYS A 661 N LEU A 654 SITE 1 AC1 11 ILE A 531 GLN A 541 ALA A 551 MET A 602 SITE 2 AC1 11 GLU A 603 CYS A 604 ASN A 606 ASP A 608 SITE 3 AC1 11 LEU A 654 ILE A 663 PRO A 673 CRYST1 70.587 106.403 114.318 90.00 90.00 90.00 I 2 2 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014167 0.000000 0.000000 0.00000 SCALE2 0.000000 0.009398 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008748 0.00000